找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

1234567
返回列表
打印 上一主題 下一主題

Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

[復(fù)制鏈接]
樓主: hierarchy
61#
發(fā)表于 2025-4-1 04:31:31 | 只看該作者
Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma,ce has been induced by cytotoxic T lymphocytes (CTLs), specific immune suppression is associated with tumor malignancy and progression. This contributes to unsatisfactory clinical outcome. In squamous cell carcinoma of the head and neck, the presence, activity, and also suppression of tumor-specific
62#
發(fā)表于 2025-4-1 07:16:33 | 只看該作者
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoetime, a second tumor, located at the kidney, however remained unaffected. The main difference in treatment being peritumoral vs. systematic application supports the hypothesis of immunosurveillance. The impact of mistletoe extract in direct contact with the tumor tissue might be explained by targete
63#
發(fā)表于 2025-4-1 11:56:23 | 只看該作者
Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas, of the first forms of immunotherapy for the treatment of sarcoma. With advancements in molecular oncology and the identification of specific sarcoma antigens, direct experimentation has been made possible in a variety of preclinical animal models. Discoveries from the laboratory have led to novel i
64#
發(fā)表于 2025-4-1 16:18:23 | 只看該作者
65#
發(fā)表于 2025-4-1 19:52:33 | 只看該作者
Immunotherapy of Lung Tumors,nly in some countries. The recent campaigns aimed at cessation of smoking have dramatically reduced cardiovascular events in some European countries. However, lung cancer remains an elusive disease with not much improvement in overall survival despite neoadjuvant chemotherapy, making this tumor a di
66#
發(fā)表于 2025-4-1 23:57:44 | 只看該作者
67#
發(fā)表于 2025-4-2 03:42:13 | 只看該作者
68#
發(fā)表于 2025-4-2 08:05:42 | 只看該作者
1234567
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 13:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
丹棱县| 正安县| 交口县| 延津县| 榆社县| 盖州市| 远安县| 枞阳县| 孝感市| 革吉县| 壶关县| 长沙县| 双鸭山市| 阿拉尔市| 双鸭山市| 大悟县| 莒南县| 鱼台县| 辉南县| 常熟市| 辛集市| 麻城市| 楚雄市| 法库县| 通化市| 巴青县| 临夏县| 永吉县| 平凉市| 永平县| 鹤峰县| 九台市| 定南县| 盐源县| 舞钢市| 定州市| 榆林市| 揭阳市| 海宁市| 安达市| 泾阳县|